Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Emergency Medicine

A 41-year-old man with HIV apparently developed cancer from a parasitic tapeworm undergoing a malignant process.
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
The FDA has approved Cangrelor, an intravenous drug that will be used to prevent blood clots in patients who receive an angioplasty, according to a report from Reuters. Cangrelor was developed by The Medicine Co. and has taken a decade to earn approval...